Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells
暂无分享,去创建一个
C. Croce | R. Aqeilan | T. Palumbo | K. Huebner | F. Pichiorri | M. Gaspari | H. Okumura | E. Gaudio | F. Trapasso | T. Druck | R. Iuliano | Dongju Park | Douglas G. Cheung | C. Raso | Kari A. C. Green | Kari Green
[1] M. Protopopova,et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability , 2018, Nature Medicine.
[2] S. Volinia,et al. The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles , 2017, Oncotarget.
[3] Santanu Banerjee,et al. Proximal Ligation Assay (PLA) on Lung Tissue and Cultured Macrophages to Demonstrate Protein-protein Interaction. , 2017, Bio-protocol.
[4] K. Huebner,et al. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression. , 2017, Biochimica et biophysica acta. Gene regulatory mechanisms.
[5] K. Huebner,et al. Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers , 2017, Cytogenetic and Genome Research.
[6] V. Papadopoulos,et al. Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies , 2016, Front. Endocrinol..
[7] F. Sotgia,et al. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells , 2016, Oncotarget.
[8] K. Huebner,et al. The FHIT gene product: tumor suppressor and genome “caretaker” , 2014, Cellular and Molecular Life Sciences.
[9] C. Brenner,et al. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1 , 2014, Cell cycle.
[10] D. Sabatini,et al. Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides , 2014, Nature.
[11] C. Croce,et al. Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel , 2013, PloS one.
[12] K. Huebner,et al. Initiation of Genome Instability and Preneoplastic Processes through Loss of Fhit Expression , 2012, PLoS genetics.
[13] C. Croce,et al. Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis , 2009, Proceedings of the National Academy of Sciences.
[14] C. Croce,et al. Fragile gene product, Fhit, in oxidative and replicative stress responses , 2009, Cancer science.
[15] C. Croce,et al. Fhit modulates the DNA damage checkpoint response. , 2006, Cancer research.
[16] Y. Sugimoto,et al. Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin , 2006, Cancer Chemotherapy and Pharmacology.
[17] M. Macleod,et al. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR , 2005, Molecular carcinogenesis.
[18] D. Iliopoulos,et al. Concordant loss of fragile gene expression early in breast cancer development , 2005, Pathology international.
[19] T. Ørntoft,et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.
[20] Dimitris Kletsas,et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions , 2005, Nature.
[21] S. Gupta,et al. HSP60, Bax, Apoptosis and the Heart , 2005, Journal of cellular and molecular medicine.
[22] C. Croce,et al. Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant , 2004, British Journal of Cancer.
[23] J. Minna,et al. Synergistic Tumor Suppression by Coexpression of FHIT and p53 Coincides with FHIT-Mediated MDM2 Inactivation and p53 Stabilization in Human Non-Small Cell Lung Cancer Cells , 2004, Cancer Research.
[24] D. Iliopoulos,et al. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma , 2004, Cancer.
[25] S. Korsmeyer,et al. Review Cell Death: Critical Control Points Another Line of Evidence for the Importance of Caspases in Cell Death Came From , 2022 .
[26] C. Croce,et al. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: Evolutionarily conserved but highly recombinogenic , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Diaz,et al. Mitochondrial localization of reactive oxygen species by dihydrofluorescein probes , 2003, Histochemistry and Cell Biology.
[28] C. Croce,et al. Regression of upper gastric cancer in mice by FHIT gene delivery , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] C. Croce,et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] Xinbin Chen,et al. The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis , 2002, Oncogene.
[31] C. Croce,et al. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Kinzler,et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil–induced apoptosis in colorectal cancer cells , 2001, Nature Medicine.
[33] C. Croce,et al. The tumor spectrum in FHIT-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] C. Croce,et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Croce,et al. Effect of adenoviral transduction of the fragile histidine triad gene into esophageal cancer cells. , 2001, Cancer research.
[36] M. Paterson,et al. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. , 2000, The Biochemical journal.
[37] L. D. Barnes,et al. The Tumor Suppressor Protein Fhit , 1999, The Journal of Biological Chemistry.
[38] J. Minna,et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. , 1999, Cancer research.
[39] C. Croce,et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. , 1998, Cancer research.
[40] L. D. Barnes,et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Roth,et al. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. , 1997, Cancer gene therapy.
[42] J. Samet,et al. Molecular damage in the bronchial epithelium of current and former smokers. , 1997, Journal of the National Cancer Institute.
[43] J S Lee,et al. Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.
[44] C. Croce,et al. The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.
[45] D. Sklan,et al. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system. , 1993, Archives of biochemistry and biophysics.
[46] K. Suzuki,et al. Components of the electron transport system in adrenal steroid hydroxylase. Isolation and properties of non-heme iron protein (adrenodoxin). , 1967, The Journal of biological chemistry.
[47] C. Croce,et al. Muir-Torre-like syndrome in Fhit-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] F. Hartl,et al. Molecular chaperone functions of heat-shock proteins. , 1993, Annual review of biochemistry.